Rynki

Twoje finanse

Biznes

Forum

SOPHARMA AD: Notification for buy-back of treasury shares

Spis treści:

1. REPORT

reklama

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
SFA buyback 08122023 espi.pdf  (REPORT)

przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 210 / 2023
Date of issue: 2023-12-07
Short name of the issuer
SOPHARMA AD
Subject
Notification for buy-back of treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Pursuant to the requirements of Art. 100t of the Law on Public Offering of Securities, "Sopharma" AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) announces that on the basis of Art. 187b of the Commercial Law and Art. 111, para. 5 and para. 6 of the Law on Public Offering of Securities and in connection with the decision of the General Meeting of Shareholders of the company, held on 4 August 2023, and the decision of the Board of Directors of the company from 7 December 2023, "Sopharma" AD notifies that the company intends to buy back treasury shares within the limit according to Art. 111, para. 5 of the Law on Public Offering of Securities.
Annexes
File Description
SFA buyback 08122023 espi.pdfSFA_buyback_08122023_espi.pdf

przewiń, aby zobaczyć całą tabelę
SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-12-07 Ognian Ivanov Donev Executive director
Źródło: Komunikaty spółek (ESPI)
powiązane
polecane
najnowsze
popularne
najnowsze
bankier na skróty